Haven't used Zhimeng Biopharma yet?
Ask Trustburn

Questions about Zhimeng Biopharma

Based on 9 reviews, listing data and website checks · updated yesterday

What is Zhimeng Biopharma?

Zhimeng Biopharma is a biopharmaceutical company that develops novel small molecule drugs to treat neurological diseases, including epilepsy, pain, and strokes. The company also focuses on chronic Hepatitis B cure development and has an investigational drug, CB03-154, intended for the treatment of amyotrophic lateral sclerosis (ALS). Their website, core-biopharma.com, provides information about their products and services.

How do customers describe the company's website?

The company's website, core-biopharma.com, is described by multiple reviewers as informative, user-friendly, and easy to navigate. Reviewers consistently praise the helpfulness of the website in making purchase decisions and understanding their offerings. The site is noted for providing all necessary information to potential customers.

What is the current Trustburn rating and review history?

Zhimeng Biopharma has received a Trustburn rating of 4 out of 5 stars from 9 reviews. The review split includes several 5-star ratings, with some 4-star and 3-star ratings as well. These reviews are dated from December 2022 to July 2023, showing recent customer feedback.

What specific drug developments and clinical trial milestones has Zhimeng Biopharma achieved?

The company is actively developing CB03-154, a next-generation potassium channel opener for ALS, which successfully completed patient enrollment in its pivotal Phase 2/3 clinical trial in October 2026. Additionally, their drug CB03 received Orphan Drug Designation from the US FDA as a potassium ion channel opener for amyotrophic lateral sclerosis.

What partnerships and industry reports mention Zhimeng Biopharma?

According to news sources, Zhimeng Biopharma has appointed global partners for its development of a Chronic Hepatitis B cure. The company is also recognized in the Hepatitis B Virus Pipeline Assessment 2022 report as a major player in this field.

What are the company's core competencies in drug development?

The company's core competencies include the development of IDO inhibitors, specifically an IDO1 inhibitor initially developed by Shanghai Zhimeng Biopharma, Inc. This drug is currently pending its highest R&D status according to drug target databases.

What common themes do customer reviews highlight about the products?

Reviewers frequently mention that Zhimeng Biopharma provides top-notch quality products and services. Many customers express satisfaction with the high quality of the products and the professionalism of the company in delivering these items.

What major historical milestones have defined Zhimeng Biopharma's growth?

The company's history includes significant milestones such as receiving FDA Orphan Drug Designation and completing pivotal clinical trial enrollments. These events demonstrate a track record of advancing drug development through regulatory approvals and clinical progress.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Kelley Daviss, SPHR
Reviews 1

👍 Zhimeng Biopharma is amazing! I have been a customer for a while, and they never disappoint. Their products are the best in the market. Their website is easy to navigate and provides all the necessary information. Keep up the good work!

Marie Lickley
Reviews 1

😊 I have been a loyal customer of Zhimeng Biopharma for years now, and I can say that I am extremely happy with their products and services. Their website is user-friendly and provides all the necessary information. I highly recommend them.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="core-biopharma-com" data-lang="en"></div>
More widgets

About Zhimeng Biopharma

Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.